Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01038271 · ClinicalTrials.gov registry record · NA
Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT01038271: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01038271 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 151 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01038271, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
The main purpose of this study is to compare two types of treatment-standard palliative care (which usually is given towards the end of life) and integrated palliative care (which is given soon after diagnosis) to see which is better for improving quality of life of participants with advanced non-small cell lung cancer. Palliative care is care that tries to lessen the symptoms of a disease. Although many people with advanced lung cancer receive palliative care or hospice toward the end of their disease, the entire course of their disease is often complicated by physical and emotional difficulties. Palliative care may be useful when it is started soon after diagnosis.
Interventions
- OTHER Standard Palliative Care Group
- OTHER Integrated Palliative Care Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2006-05 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01038271
The ClinicalTrials.gov registry entry for NCT01038271 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Palliative Care Group is the first listed.
NCT01038271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01038271 about?
NCT01038271 is a clinical study titled "Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)". The main purpose of this study is to compare two types of treatment-standard palliative care (which usually is given towards the end of life) and integrated palliative care (which is given soon after diagnosis) to see which is better for improving quality of life of participants with advanced non-sm...
What is the current status of trial NCT01038271?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2006-05. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01038271?
The interventions under investigation include: Standard Palliative Care Group (OTHER), Integrated Palliative Care Intervention (OTHER).
Who is sponsoring clinical trial NCT01038271?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.